Quick10K

⚲

Lingerie Fighting Championships

Filings

10-Q	2019-09-30	Filed 2019-12-06
10-Q	2019-06-30	Filed 2019-11-29
10-Q	2019-03-31	Filed 2019-05-15
10-K	2018-12-31	Filed 2019-04-16
10-Q	2018-09-30	Filed 2018-11-07
10-Q	2018-06-30	Filed 2018-09-11
10-Q	2018-03-31	Filed 2018-08-16
10-K	2017-12-31	Filed 2018-07-20
10-Q	2017-09-30	Filed 2018-03-05
10-Q	2017-06-30	Filed 2018-01-25
10-Q	2017-03-31	Filed 2017-07-06
10-K	2016-12-31	Filed 2017-06-01
10-Q	2016-09-30	Filed 2016-11-14
10-Q	2016-06-30	Filed 2016-08-15
10-Q	2016-03-31	Filed 2016-05-13
10-K	2015-12-31	Filed 2016-04-14
10-Q	2015-09-30	Filed 2015-11-13
10-Q	2015-06-30	Filed 2015-08-14
10-Q	2015-03-31	Filed 2015-05-20
10-K	2015-02-28	Filed 2015-06-03
10-Q	2014-11-30	Filed 2015-01-14
10-Q	2014-08-31	Filed 2014-10-09
10-Q	2014-05-31	Filed 2014-07-09
10-K	2014-02-28	Filed 2014-05-29
10-Q	2013-11-30	Filed 2014-01-17
10-Q	2013-08-31	Filed 2013-10-18
10-Q	2013-05-31	Filed 2013-07-16
10-K	2013-02-28	Filed 2013-06-13
10-Q	2012-11-30	Filed 2013-01-22
10-Q	2012-08-31	Filed 2012-10-19
10-Q	2012-05-31	Filed 2012-07-23
10-K	2012-02-29	Filed 2012-07-10
10-Q	2011-11-30	Filed 2012-01-23
10-Q	2011-08-31	Filed 2011-10-24
10-Q	2011-05-31	Filed 2011-07-19
10-K	2011-02-28	Filed 2011-06-15
10-Q	2010-11-30	Filed 2011-01-19
10-Q	2010-08-31	Filed 2010-10-19
10-Q	2010-05-31	Filed 2010-07-20
10-K	2010-02-28	Filed 2010-07-19
10-Q	2009-11-30	Filed 2010-02-12

Reports

8-K	2018-03-28
8-K	2018-03-05

Lingerie Fighting Championships Financials

BOTY Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
OWC Pharmaceutical Research (OWCP)	0	0%	-0.2	362%	1,773	1,467	100	0	6,420	6,420	-1,465
Headhunter Group (HHR)
United States Short Oil Fund (DNO)	0	-0%	0.0		0	0	-600	0	-1,856	-1,856	-0
Immune Therapeutics (IMUN)	0		0.0	-29,381%	8	13,479	0	0	-2,476	-2,475	-6
Juniper Industrial (JIH)
PositiveID Corp (PSID)
Live Current Media (LIVC)	0		2.8	-26%	418	108	0	0	-110	-109	-306
Sun Pacific Holding (SNPW)	0	30%	-17.5	-20%	6,669	10,975	260	77	-1,301	-315	5,510
Digatrade Financial (DIGAF)	0			0%	527	778	0	0	0	0	0
Lingerie Fighting Championships (BOTY)	0	-49%	0.2	-8,950,200%			23	-11	90	-10	-2
New Century Resources (NCRE)	0		0.0		0	205	0	0	-18	-17	-0
Arete Industries (ARET)
Renewable Energy Acquisition (REAC)	0		0.0	2,353,600%			0	0	-24	-22	-0
Sundial Growers (SNDL)
Energy Transfer Operating (ETP)	0	27%	5.8	4%	95,247,000	59,636,000	40,493,000	10,886,000	3,786,000	8,016,000	46,523,000
Blue Line Protection Group (BLPG)	0	40%	0.0	-189%	1,661	5,917	3,017	1,201	-3,138	-2,534	-19
ABCO Energy (ABCE)	0	38%	0.1	-173%	411	1,359	1,627	622	-713	-502	-28
Guided Therapeutics (GTHP)	0	332%	0.1	1,462%	404	16,413	28	93	5,908	6,835	439
Endonovo Therapeutics (ENDV)	0	73%	-0.8	-301%	3,414	19,980	204	150	-10,268	-9,617	7,448
Dominovas Energy (DNRG)


Balance Sheet ($'000)	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	2	5	1	63	16	6	12	4	61	36	19	3	2	4	7	117	26	22	10	22	50	58	32	1	0	28	10	1	34	3	102	28	2
Accounts Receivable	91	40	22														15
Inventory		6	9
PP&E	96	92	85	0	0	0
Assets	583	471	388	147	58	6	12	4	61	36	19	3	2	4
Accounts Payable	137	72	43
Long-Term Debt	0
Liabilities	2,032	2,194	2,381	1,031	183	226	118	158	177	215	247	270	8	42
Stockholders' Equity						-220	-106	-154	-115	-180	-228	-267	-6	-39	153	117	25	-16	-21	-324	-550	-1,232	-1,099	-1,147	-1,590	-2,455	-3,855	-2,375	-2,714	-2,255	-2,342	-2,551	-2,555


Income Statement ($'000)	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	34	73	39	0	0	0	0	0	0	0	0	0				0	19	-13	1	3	15	50		10	6	0	2	2	9		1	2	19
Cost of Revenue	180	16	18	0	0	0										14	30	-11	0	41	11	54	21	6	19	8	20	1	2		0	11	22
Gross Profit	-147	57	21	0	0	0										-14	-11	-2	1	-38	4	-4	-21	3	-13	-8	-19	0	6		1	-9	-3
R&D
SG&A	365	368	300	125	92	82	86	48	62	64	48	39	9	40	15	31	81	44	6	78	85	264	97	59	57	42	78	49	57		55	82	45
Tax	-0	3	3	0	0	0	0	0	0	0	0	0			0	-0	0	0			0		0	0		0	0		0		0	0	0
Net Income	-691	-313	-282	-125	-184		-86	-48	-62	-64	-48	-39	-9	-32	-21	-44	-92	-41	-5	-203	-256	-1,339	-63	-48	-579	-867	-1,431	1,480	-350		-99	290	-102


Cash Flow ($'000)	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		-173	-166	-83	-22	-10	-69	-7	-43	-26	-17	-16		-34	-5	-54	-91	-4	-12	-132	-52	-53	-71	-31		-61	-68		-47		-17		-26
Cash Investing		-9	0	0	0	0	0								3	0	0	0											0		0	0
Cash Financing		186	162	150	-25	0	75	0	100	0	0	0			5	164	0	0	-0	144	80	60	45	0		87	50		80		116		0